Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,045) with videos related to
Page
of 105
Sort By:
The Journal of Pathology
|
May 18, 2020
Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification
Xiao-Tong Wang, Ru Fang, Ru-Song Zhang, et al.
Journal of the American Society of Nephrology : JASN
|
February 7, 2023
Genome-Wide Association Study in Acute Tubulointerstitial Nephritis
Xu-Jie Zhou, Tao Su, Jingyuan Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 16, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
Fang Fang, Jun Lu, Xu Sang, et al.
Leukemia & Lymphoma
|
September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms
Xing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Cell Death & Disease
|
February 24, 2022
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
Zi-Mu Zhang, Hai-Bo Cao, Zhi-Heng Li, et al.
Journal of Hematology & Oncology
|
October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
Ya-Fang Ma, Ying Lu, Qian Wu, et al.
Journal of Immunology Research
|
November 28, 2022
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
Si-Qi Jia, Ran Zhuo, Zi-Mu Zhang, et al.
Oncology Letters
|
October 29, 2021
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
Yan-Ling Chen, Zi-Mu Zhang, Xiao-Lu Li, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Zhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, et al.
Cell & Bioscience
|
March 19, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Yan-Ling Chen, Xiao-Lu Li, Gen Li, et al.
Page
of 105
Search research articles
Search
Showing results (1031-1040 of 1,045) with videos related to
Sort By:
Page
of 105
The Journal of Pathology
|
May 18, 2020
Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification
Xiao-Tong Wang, Ru Fang, Ru-Song Zhang, et al.
Journal of the American Society of Nephrology : JASN
|
February 7, 2023
Genome-Wide Association Study in Acute Tubulointerstitial Nephritis
Xu-Jie Zhou, Tao Su, Jingyuan Xie, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 16, 2022
Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
Fang Fang, Jun Lu, Xu Sang, et al.
Leukemia & Lymphoma
|
September 16, 2015
Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms
Xing-Nong Ye, Xin-Ping Zhou, Ju-Ying Wei, et al.
Cell Death & Disease
|
February 24, 2022
SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
Zi-Mu Zhang, Hai-Bo Cao, Zhi-Heng Li, et al.
Journal of Hematology & Oncology
|
October 18, 2022
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
Ya-Fang Ma, Ying Lu, Qian Wu, et al.
Journal of Immunology Research
|
November 28, 2022
The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
Si-Qi Jia, Ran Zhuo, Zi-Mu Zhang, et al.
Oncology Letters
|
October 29, 2021
MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1
Yan-Ling Chen, Zi-Mu Zhang, Xiao-Lu Li, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Zhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, et al.
Cell & Bioscience
|
March 19, 2022
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Yan-Ling Chen, Xiao-Lu Li, Gen Li, et al.
Page
of 105